chr1:94994729:> Detail (hg19)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr1:94,994,729-95,007,315 |
| hg38 | chr1:94,529,173-94,541,759 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| <0.001 | Cardiomyopathy, Dilated | NA | BeFree | Detail | |
| 0.005 | Cardiovascular Diseases | NA | BeFree,LHGDN | Detail | |
| 0.003 | carotid stenosis | NA | BeFree,GAD | Detail | |
| 0.005 | brain ischemia | NA | GAD | Detail | |
| <0.001 | Transient ischemic attack | NA | BeFree | Detail | |
| <0.001 | Malignant tumor of cervix | NA | BeFree | Detail | |
| <0.001 | cholestasis | NA | BeFree | Detail | |
| 0.002 | chorioamnionitis | NA | GAD | Detail | |
| <0.001 | hemophilia B | NA | BeFree | Detail | |
| <0.001 | colitis | NA | BeFree | Detail | |
| 0.002 | colorectal carcinoma | NA | BeFree | Detail | |
| 0.005 | Colorectal Neoplasms | NA | LHGDN | Detail | |
| 0.001 | Coronary Arteriosclerosis | NA | BeFree | Detail | |
| 0.002 | Coronary heart disease | In conclusion, HDL from CHD and ACS patients loses the ability of healthy HDL to... | BeFree | 25056722 | Detail |
| <0.001 | coronary thrombosis | NA | BeFree | Detail | |
| 0.003 | Cessation of life | NA | LHGDN | Detail | |
| <0.001 | Mental Depression | NA | BeFree | Detail | |
| <0.001 | depressive disorder | NA | BeFree | Detail | |
| 0.001 | Diabetes | NA | BeFree | Detail | |
| 0.001 | diabetes mellitus | NA | BeFree | Detail | |
| 0.011 | Diabetes Mellitus, Non-Insulin-Dependent | NA | BeFree,GAD,LHGDN | Detail | |
| 0.124 | disseminated intravascular coagulation | Initial laboratory testing showed thrombocytopenia, further testing showed deran... | BeFree,CTD_human | 22713531 | Detail |
| 0.124 | disseminated intravascular coagulation | Delayed bleeding is often ascribed to consumptive coagulopathy initiated by expo... | BeFree,CTD_human | 25673638 | Detail |
| <0.001 | Bacterial Endocarditis | NA | BeFree | Detail | |
| <0.001 | endometriosis | NA | BeFree | Detail | |
| <0.001 | Disorder of eye | NA | BeFree | Detail | |
| <0.001 | factor V deficiency | NA | BeFree | Detail | |
| <0.001 | factor VII deficiency | NA | BeFree | Detail | |
| 0.001 | factor XI deficiency | NA | BeFree | Detail | |
| 0.002 | Fetal Membranes, Premature Rupture | NA | GAD | Detail | |
| <0.001 | fibrosarcoma | NA | BeFree | Detail | |
| 0.003 | Fibrosis | NA | LHGDN | Detail | |
| <0.001 | Foramen Ovale, Patent | NA | BeFree | Detail | |
| 0.002 | glioblastoma | NA | BeFree | Detail | |
| 0.003 | Glioma | NA | BeFree | Detail | |
| <0.001 | Graves Disease | NA | BeFree | Detail | |
| <0.001 | congenital heart defects | NA | BeFree | Detail | |
| <0.001 | Heart Diseases | NA | BeFree | Detail | |
| 0.003 | hemolytic-uremic syndrome | NA | BeFree,LHGDN | Detail | |
| 0.002 | Hemophilia A | NA | BeFree | Detail | |
| <0.001 | Herpes Simplex Infections | NA | BeFree | Detail | |
| <0.001 | HIV Infections | NA | BeFree | Detail | |
| <0.001 | homocystinuria | NA | BeFree | Detail | |
| <0.001 | Hypercholesterolemia | NA | BeFree | Detail | |
| <0.001 | Hypercholesterolemia, Familial | NA | BeFree | Detail | |
| 0.004 | Hypertensive disease | NA | BeFree,LHGDN | Detail | |
| 0.004 | pulmonary hypertension | NA | BeFree,LHGDN | Detail | |
| <0.001 | Immunologic Deficiency Syndromes | NA | BeFree | Detail | |
| <0.001 | ischemia | These findings demonstrate that TF-rich mEMPs released by microvascular endothel... | BeFree | 25425620 | Detail |
| <0.001 | Kidney Diseases | NA | BeFree | Detail | |
| 0.005 | Kidney Failure, Chronic | NA | GAD,LHGDN | Detail | |
| 0.002 | Premature Obstetric Labor | NA | GAD | Detail | |
| <0.001 | Fibroid Tumor | NA | BeFree | Detail | |
| <0.001 | leiomyosarcoma | NA | BeFree | Detail | |
| 0.004 | leukemia | NA | BeFree,LHGDN | Detail | |
| <0.001 | chronic lymphocytic leukemia | NA | BeFree | Detail | |
| 0.001 | acute monocytic leukemia | NA | BeFree | Detail | |
| 0.001 | Leukemia, Myelocytic, Acute | NA | BeFree | Detail | |
| 0.123 | acute promyelocytic leukemia | NA | BeFree,CTD_human | Detail | |
| 0.123 | liver cirrhosis | NA | BeFree,CTD_human,LHGDN | Detail | |
| 0.001 | Lung Neoplasms | NA | BeFree | Detail | |
| <0.001 | Lupus Vulgaris | NA | BeFree | Detail | |
| <0.001 | Lupus Erythematosus, Discoid | NA | BeFree | Detail | |
| 0.002 | Lupus Erythematosus, Systemic | NA | BeFree | Detail | |
| 0.003 | Lymphatic Metastasis | NA | LHGDN | Detail | |
| <0.001 | malaria | NA | BeFree | Detail | |
| <0.001 | Malaria, Falciparum | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of stomach | NA | BeFree | Detail | |
| 0.008 | melanoma | NA | BeFree,LHGDN | Detail | |
| 0.003 | meningioma | NA | LHGDN | Detail | |
| <0.001 | Meningococcal Infections | NA | BeFree | Detail | |
| <0.001 | Mesothelioma | NA | BeFree | Detail | |
| 0.003 | Multiple Organ Failure | NA | LHGDN | Detail | |
| <0.001 | Myelomonocytic leukemia | NA | BeFree | Detail | |
| 0.010 | myocardial infarction | According to RT-PCR cycle threshold (Ct), TF gene expression was higher in eosin... | BeFree,LHGDN | 25375118 | Detail |
| 0.003 | myocarditis | NA | LHGDN | Detail | |
| 0.017 | Neoplasm Metastasis | NA | BeFree,LHGDN | Detail | |
| 0.123 | nephrotic syndrome | NA | CTD_human,LHGDN | Detail | |
| <0.001 | obesity | NA | BeFree | Detail | |
| <0.001 | ovarian carcinoma | NA | BeFree | Detail | |
| <0.001 | Ovarian Diseases | NA | BeFree | Detail | |
| 0.006 | Pancreatic Neoplasm | NA | BeFree,LHGDN | Detail | |
| 0.002 | pre-eclampsia | NA | GAD | Detail | |
| <0.001 | Pregnancy Complications | NA | BeFree | Detail | |
| 0.005 | Prostatic Neoplasms | NA | LHGDN | Detail | |
| 0.003 | proteinuria | NA | LHGDN | Detail | |
| <0.001 | pulmonary embolism | A deep vein thrombosis model of electrolytic inferior vena cava injury and pulmo... | BeFree | 26251307 | Detail |
| <0.001 | pulmonary fibrosis | NA | BeFree | Detail | |
| 0.120 | Purpura, Thrombotic Thrombocytopenic | NA | CTD_human | Detail | |
| 0.003 | Rectal Neoplasms | NA | LHGDN | Detail | |
| <0.001 | Respiratory Distress Syndrome, Newborn | NA | BeFree | Detail | |
| 0.006 | Respiratory Distress Syndrome, Adult | NA | BeFree,LHGDN | Detail | |
| <0.001 | rhabdomyosarcoma | NA | BeFree | Detail | |
| 0.003 | Rheumatism | NA | LHGDN | Detail | |
| <0.001 | Rocky Mountain spotted fever | NA | BeFree | Detail | |
| 0.003 | schistosomiasis | NA | LHGDN | Detail | |
| <0.001 | Septicaemia due to gram-negative organism, unspecified | NA | BeFree | Detail | |
| 0.003 | Septicemia | Seventeen SNPs in TF and TFPI were genotyped in samples of sepsis (n =577) and s... | BeFree | 25407675 | Detail |
| 0.003 | Septicemia | Tissue factor (TF) is a key initiating component in intravascular coagulation in... | BeFree | 26241501 | Detail |
| 0.003 | Septic Shock | NA | LHGDN | Detail | |
| <0.001 | Sinus Thrombosis, Intracranial | NA | BeFree | Detail | |
| 0.003 | Stomach Neoplasms | NA | LHGDN | Detail | |
| 0.006 | Cerebrovascular accident | NA | BeFree,GAD,LHGDN | Detail | |
| <0.001 | Thrombocythemia, Essential | NA | BeFree | Detail | |
| 0.003 | Thromboembolism | Genetic polymorphisms and plasma levels of tissue factor and tissue factor pathw... | BeFree | 24448154 | Detail |
| 0.136 | thrombosis | NA | CTD_human,GAD,LHGDN | Detail | |
| <0.001 | Thyroid Neoplasm | NA | BeFree | Detail | |
| <0.001 | tuberculosis | NA | BeFree | Detail | |
| 0.003 | urticaria | NA | LHGDN | Detail | |
| <0.001 | Uterine Fibroids | NA | BeFree | Detail | |
| 0.008 | Vascular Diseases | NA | BeFree,GAD,LHGDN | Detail | |
| 0.120 | Venous Thrombosis | NA | CTD_human | Detail | |
| <0.001 | Virus Diseases | NA | BeFree | Detail | |
| <0.001 | Yersinia infections | NA | BeFree | Detail | |
| <0.001 | Peripheral Vascular Diseases | NA | BeFree | Detail | |
| 0.001 | severe combined immunodeficiency | NA | BeFree | Detail | |
| <0.001 | Foot Ulcer | NA | BeFree | Detail | |
| 0.002 | antiphospholipid syndrome | NA | BeFree | Detail | |
| 0.002 | Polyendocrinopathies, Autoimmune | NA | BeFree | Detail | |
| <0.001 | Liver failure | NA | BeFree | Detail | |
| <0.001 | acute leukemia | NA | BeFree | Detail | |
| <0.001 | benign neoplasm | NA | BeFree | Detail | |
| <0.001 | Adnexal mass | NA | BeFree | Detail | |
| <0.001 | Deep Vein Thrombosis | NA | BeFree | Detail | |
| <0.001 | Small cell carcinoma of lung | NA | BeFree | Detail | |
| 0.005 | Premature Birth | NA | GAD | Detail | |
| 0.123 | Myocardial Ischemia | NA | BeFree,CTD_human,GAD | Detail | |
| 0.001 | Arterial thrombosis | NA | BeFree | Detail | |
| <0.001 | Adenocarcinoma of lung (disorder) | NA | BeFree | Detail | |
| <0.001 | Secondary malignant neoplasm of lung | NA | BeFree | Detail | |
| <0.001 | acute myocardial infarction | NA | BeFree | Detail | |
| 0.005 | Tumor Progression | In this study, we show that senescent human umbilical vein endothelial cells los... | BeFree | 25038529 | Detail |
| 0.005 | Tumor Progression | This study indicates that genetic and phenotypic variation of both TFPIα and TFP... | BeFree | 25882602 | Detail |
| <0.001 | Idiopathic hypereosinophilic syndrome | According to RT-PCR cycle threshold (Ct), TF gene expression was higher in eosin... | BeFree | 25375118 | Detail |
| <0.001 | uveal melanoma | NA | BeFree | Detail | |
| <0.001 | Intravascular hemolysis | NA | BeFree | Detail | |
| 0.002 | pancreatic carcinoma | NA | BeFree | Detail | |
| <0.001 | Hereditary pancreatitis | NA | BeFree | Detail | |
| <0.001 | Fibrosis, Liver | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of lung | NA | BeFree | Detail | |
| <0.001 | age related macular degeneration | NA | BeFree | Detail | |
| 0.003 | Disease Progression | NA | LHGDN | Detail | |
| 0.006 | Sepsis | Seventeen SNPs in TF and TFPI were genotyped in samples of sepsis (n =577) and s... | BeFree,LHGDN | 25407675 | Detail |
| 0.006 | Sepsis | Tissue factor (TF) is a key initiating component in intravascular coagulation in... | BeFree,LHGDN | 26241501 | Detail |
| <0.001 | Heparin-induced thrombocytopenia | NA | BeFree | Detail | |
| <0.001 | Severe hereditary factor VIII deficiency disease | NA | BeFree | Detail | |
| <0.001 | Carcinoma breast stage IV | NA | BeFree | Detail | |
| <0.001 | gastric adenocarcinoma | NA | BeFree | Detail | |
| <0.001 | Metastatic melanoma | NA | BeFree | Detail | |
| <0.001 | cervical squamous cell carcinoma | NA | BeFree | Detail | |
| 0.001 | Solid tumour | NA | BeFree | Detail | |
| <0.001 | stage, prostate cancer | NA | BeFree | Detail | |
| <0.001 | Adenocarcinoma of pancreas | NA | BeFree | Detail | |
| <0.001 | Vascular Neoplasms | Triggering tissue factor (F3/TF) and thrombin receptors (F2R/PAR-1) may influenc... | BeFree | 25163932 | Detail |
| <0.001 | cervix carcinoma | NA | BeFree | Detail | |
| <0.001 | Lupus anticoagulant disorder | NA | BeFree | Detail | |
| <0.001 | Restenosis | NA | BeFree | Detail | |
| <0.001 | Platelet thrombus | NA | BeFree | Detail | |
| <0.001 | Tumor necrosis | Infusion of recombinant monoclonal anti-PLVAP Fab-TF into the main tumor feeding... | BeFree | 25376302 | Detail |
| <0.001 | anaplastic astrocytoma | NA | BeFree | Detail | |
| <0.001 | Stable angina | NA | BeFree | Detail | |
| <0.001 | Deep vein thrombosis of lower limb | NA | BeFree | Detail | |
| <0.001 | endometriosis of uterus | NA | BeFree | Detail | |
| <0.001 | malignant mesothelioma | NA | BeFree | Detail | |
| 0.002 | Malignant neoplasm of pancreas | NA | BeFree | Detail | |
| 0.001 | Malignant neoplasm of prostate | NA | BeFree | Detail | |
| <0.001 | Hematologic Neoplasms | NA | BeFree | Detail | |
| 0.080 | Endotoxemia | NA | RGD | Detail | |
| <0.001 | Trousseau's syndrome | NA | BeFree | Detail | |
| 0.004 | thrombophilia | NA | BeFree | Detail | |
| <0.001 | Idiopathic crescentic glomerulonephritis | NA | BeFree | Detail | |
| <0.001 | Chronic rejection of renal transplant | NA | BeFree | Detail | |
| <0.001 | lupus erythematosus | NA | BeFree | Detail | |
| <0.001 | Acute monoblastic leukemia | NA | BeFree | Detail | |
| <0.001 | Secondary malignant neoplasm of liver | NA | BeFree | Detail | |
| <0.001 | Benign neurologic neoplasms | NA | BeFree | Detail | |
| 0.003 | Metabolic syndrome X | NA | BeFree,GAD | Detail | |
| <0.001 | Chiari malformation type II | NA | BeFree | Detail | |
| 0.003 | Factor V Leiden mutation | A deep vein thrombosis model of electrolytic inferior vena cava injury and pulmo... | BeFree | 26251307 | Detail |
| <0.001 | Carcinogenesis | Among miRNAs screened, we found that miR340 expression was decreased in all huma... | BeFree | 25627976 | Detail |
| <0.001 | hyperhomocysteinemia | NA | BeFree | Detail | |
| <0.001 | monocytic leukemia | NA | BeFree | Detail | |
| <0.001 | Tumor Initiation | NA | BeFree | Detail | |
| 0.001 | prostate carcinoma | NA | BeFree | Detail | |
| <0.001 | Thrombocythemia, Essential | These results support a role for platelet turnover, factor V, and aAPCR in the t... | BeFree | 19105233 | Detail |
| 0.008 | Activated Protein C Resistance | 366 breast cancer patients and 307 controls were genotyped for SNPs (n = 41) in ... | BeFree | 25407022 | Detail |
| <0.001 | Vascular Hemostatic Disorders | NA | BeFree | Detail | |
| 0.006 | THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE (disorder) | These results support a role for platelet turnover, factor V, and aAPCR in the t... | BeFree | 19105233 | Detail |
| <0.001 | Epithelial ovarian cancer | NA | BeFree | Detail | |
| 0.007 | breast carcinoma | To characterize the molecular mechanism and map the response element used by pro... | BeFree | 24853881 | Detail |
| 0.007 | breast carcinoma | To investigate the molecular mechanisms controlling cancer and hemostasis, we co... | BeFree | 25407022 | Detail |
| 0.007 | breast carcinoma | These findings have functional implications in the pathobiology of thromboemboli... | BeFree | 25447311 | Detail |
| 0.007 | breast carcinoma | The effect of tumor expressed TF and TFPIα and TFPIβ on survival was investigate... | BeFree | 25882602 | Detail |
| 0.008 | Activated Protein C Resistance | These results support a role for platelet turnover, factor V, and aAPCR in the t... | BeFree | 19105233 | Detail |
| <0.001 | Carcinoma of lung | NA | BeFree | Detail | |
| 0.001 | Hemophilia, NOS | NA | BeFree | Detail | |
| <0.001 | Secondary malignant neoplasm of lymph node | NA | BeFree | Detail | |
| 0.002 | colon carcinoma | NA | BeFree | Detail | |
| <0.001 | stomach carcinoma | NA | BeFree | Detail | |
| <0.001 | Carcinoma of bladder | NA | BeFree | Detail | |
| <0.001 | Dissecting aneurysm of the thoracic aorta | Importantly, administration of valsartan (20 mg/kg, i.p) for 8 weeks significant... | BeFree | 25109475 | Detail |
| <0.001 | asthma adult onset | NA | BeFree | Detail | |
| <0.001 | Hypereosinophilia | Enhanced tissue factor expression by blood eosinophils from patients with hypere... | BeFree | 25375118 | Detail |
| <0.001 | Carotid Artery Plaque | NA | BeFree | Detail | |
| <0.001 | malignant pleural mesothelioma | NA | BeFree | Detail | |
| <0.001 | thrombocytosis | NA | BeFree | Detail | |
| <0.001 | Arteriopathic disease | NA | BeFree | Detail | |
| <0.001 | Invasive breast carcinoma | NA | BeFree | Detail | |
| <0.001 | Endothelial dysfunction | This study indicates that in UA patients, the increase of miR-19b wrapped in EMP... | BeFree | 24998411 | Detail |
| <0.001 | Cholestatic liver disease | NA | BeFree | Detail | |
| <0.001 | transient cerebral ischemia | NA | BeFree | Detail | |
| <0.001 | ovarian neoplasm | NA | BeFree | Detail | |
| <0.001 | Vascular inflammations | These results suggest that direct Cx32-mediated interaction modulates TF express... | BeFree | 25171777 | Detail |
| <0.001 | Ischemic stroke | NA | BeFree | Detail | |
| 0.014 | Acute coronary syndrome | In conclusion, HDL from CHD and ACS patients loses the ability of healthy HDL to... | BeFree,GAD,LHGDN | 25056722 | Detail |
| <0.001 | Chlamydia pneumoniae infection | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of ovary | NA | BeFree | Detail | |
| 0.001 | M5b Acute differentiated monocytic leukemia | NA | BeFree | Detail | |
| <0.001 | Monoblastic leukemia | NA | BeFree | Detail | |
| <0.001 | pancreatic ductal adenocarcinoma | NA | BeFree | Detail | |
| <0.001 | Cardiac fibrosis | NA | BeFree | Detail | |
| 0.131 | Mammary Neoplasms | NA | BeFree,CTD_human,LHGDN | Detail | |
| <0.001 | Tumor-Associated Vasculature | NA | BeFree | Detail | |
| 0.001 | Tumor Angiogenesis | NA | BeFree | Detail | |
| <0.001 | Xenograft Model | NA | BeFree | Detail | |
| 0.002 | colorectal cancer | NA | BeFree | Detail | |
| <0.001 | Non-ST elevation (NSTEMI) myocardial infarction | NA | BeFree | Detail | |
| <0.001 | Glioblastoma multiforme | NA | BeFree | Detail | |
| <0.001 | Cirrhosis | NA | BeFree | Detail | |
| 0.001 | tumor vasculature | NA | BeFree | Detail | |
| <0.001 | Severe Sepsis | Genetic variation in the tissue factor gene is associated with clinical outcome ... | BeFree | 25407675 | Detail |
| 0.006 | THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE (disorder) | 366 breast cancer patients and 307 controls were genotyped for SNPs (n = 41) in ... | BeFree | 25407022 | Detail |
| 0.003 | Venous thromboembolism | NA | LHGDN | Detail | |
| 0.004 | coronary artery disease | NA | BeFree,LHGDN | Detail | |
| <0.001 | liver carcinoma | The results of this study suggest that anti-PLVAP Fab-TF may be used to treat HC... | BeFree | 25376302 | Detail |
| <0.001 | Heparin induced thrombocytopenia (HIT) | Finally, higher tissue factor messenger RNA levels were measured in the whole bl... | BeFree | 25680756 | Detail |
| 0.002 | Infection of amniotic sac and membranes, unspecified, unspecified trimester, not applicable or unspecified | NA | GAD | Detail | |
| <0.001 | Melena due to gastrointestinal hemorrhage | NA | BeFree | Detail | |
| <0.001 | Ischemic Cerebrovascular Accident | NA | BeFree | Detail | |
| <0.001 | Homocysteinemia | NA | BeFree | Detail | |
| 0.003 | Infection | NA | LHGDN | Detail | |
| 0.003 | adenocarcinoma | NA | BeFree,LHGDN | Detail | |
| <0.001 | adenoma | NA | BeFree | Detail | |
| <0.001 | Adnexal Diseases | NA | BeFree | Detail | |
| <0.001 | AIDS related complex | NA | BeFree | Detail | |
| 0.002 | Albuminuria | NA | GAD | Detail | |
| 0.002 | Alzheimer's disease | NA | GAD | Detail | |
| <0.001 | Anemia, Hemolytic | NA | BeFree | Detail | |
| 0.001 | Anemia, Sickle Cell | NA | BeFree | Detail | |
| 0.001 | Angina, Unstable | NA | BeFree | Detail | |
| 0.003 | Arterial Occlusive Diseases | NA | LHGDN | Detail | |
| 0.002 | arteriosclerosis | NA | BeFree | Detail | |
| <0.001 | arthritis | NA | BeFree | Detail | |
| <0.001 | rheumatoid arthritis | NA | BeFree | Detail | |
| <0.001 | asthma | NA | BeFree | Detail | |
| <0.001 | Astrocytoma | NA | BeFree | Detail | |
| 0.010 | atherosclerosis | NA | BeFree,GAD,LHGDN | Detail | |
| 0.003 | atrial fibrillation | NA | LHGDN | Detail | |
| <0.001 | Autoimmune Diseases | NA | BeFree | Detail | |
| <0.001 | Bacterial Infections | NA | BeFree | Detail | |
| 0.003 | Blood Coagulation Disorders | NA | BeFree | Detail | |
| <0.001 | borderline personality disorder | NA | BeFree | Detail | |
| 0.007 | Malignant neoplasm of breast | To characterize the molecular mechanism and map the response element used by pro... | BeFree | 24853881 | Detail |
| 0.007 | Malignant neoplasm of breast | To investigate the molecular mechanisms controlling cancer and hemostasis, we co... | BeFree | 25407022 | Detail |
| 0.007 | Malignant neoplasm of breast | These findings have functional implications in the pathobiology of thromboemboli... | BeFree | 25447311 | Detail |
| 0.007 | Malignant neoplasm of breast | The effect of tumor expressed TF and TFPIα and TFPIβ on survival was investigate... | BeFree | 25882602 | Detail |
| <0.001 | bronchopulmonary dysplasia | NA | BeFree | Detail | |
| 0.002 | Malignant tumor of colon | NA | BeFree | Detail | |
| 0.001 | Non-small cell lung carcinoma | NA | BeFree | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In conclusion, HDL from CHD and ACS patients loses the ability of healthy HDL to suppress TF and to ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Initial laboratory testing showed thrombocytopenia, further testing showed deranged prothrombin time... | DisGeNET | Detail |
| Delayed bleeding is often ascribed to consumptive coagulopathy initiated by exposed brain tissue fac... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| These findings demonstrate that TF-rich mEMPs released by microvascular endothelial cells can overco... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| According to RT-PCR cycle threshold (Ct), TF gene expression was higher in eosinophils from patients... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| A deep vein thrombosis model of electrolytic inferior vena cava injury and pulmonary embolism models... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Seventeen SNPs in TF and TFPI were genotyped in samples of sepsis (n =577) and severe sepsis patient... | DisGeNET | Detail |
| Tissue factor (TF) is a key initiating component in intravascular coagulation in sepsis, and long pe... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Genetic polymorphisms and plasma levels of tissue factor and tissue factor pathway inhibitor in veno... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In this study, we show that senescent human umbilical vein endothelial cells lose their ability to i... | DisGeNET | Detail |
| This study indicates that genetic and phenotypic variation of both TFPIα and TFPIβ, more than TF, ar... | DisGeNET | Detail |
| According to RT-PCR cycle threshold (Ct), TF gene expression was higher in eosinophils from patients... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Seventeen SNPs in TF and TFPI were genotyped in samples of sepsis (n =577) and severe sepsis patient... | DisGeNET | Detail |
| Tissue factor (TF) is a key initiating component in intravascular coagulation in sepsis, and long pe... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Triggering tissue factor (F3/TF) and thrombin receptors (F2R/PAR-1) may influence the vascular tumor... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Infusion of recombinant monoclonal anti-PLVAP Fab-TF into the main tumor feeding artery induced tumo... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| A deep vein thrombosis model of electrolytic inferior vena cava injury and pulmonary embolism models... | DisGeNET | Detail |
| Among miRNAs screened, we found that miR340 expression was decreased in all human GICs and in human ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| These results support a role for platelet turnover, factor V, and aAPCR in the thrombosis of ET as w... | DisGeNET | Detail |
| 366 breast cancer patients and 307 controls were genotyped for SNPs (n = 41) in the F2, F3 (TF), F5,... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| These results support a role for platelet turnover, factor V, and aAPCR in the thrombosis of ET as w... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| To characterize the molecular mechanism and map the response element used by progesterone (P) to upr... | DisGeNET | Detail |
| To investigate the molecular mechanisms controlling cancer and hemostasis, we conducted a case-contr... | DisGeNET | Detail |
| These findings have functional implications in the pathobiology of thromboembolic events and regulat... | DisGeNET | Detail |
| The effect of tumor expressed TF and TFPIα and TFPIβ on survival was investigated in a merged breast... | DisGeNET | Detail |
| These results support a role for platelet turnover, factor V, and aAPCR in the thrombosis of ET as w... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Importantly, administration of valsartan (20 mg/kg, i.p) for 8 weeks significantly reduced plasma TF... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Enhanced tissue factor expression by blood eosinophils from patients with hypereosinophilia: a possi... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| This study indicates that in UA patients, the increase of miR-19b wrapped in EMPs due to endothelial... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| These results suggest that direct Cx32-mediated interaction modulates TF expression in ECs during va... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In conclusion, HDL from CHD and ACS patients loses the ability of healthy HDL to suppress TF and to ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Genetic variation in the tissue factor gene is associated with clinical outcome in severe sepsis pat... | DisGeNET | Detail |
| 366 breast cancer patients and 307 controls were genotyped for SNPs (n = 41) in the F2, F3 (TF), F5,... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The results of this study suggest that anti-PLVAP Fab-TF may be used to treat HCC cases for which tr... | DisGeNET | Detail |
| Finally, higher tissue factor messenger RNA levels were measured in the whole blood of 131RR donors ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| To characterize the molecular mechanism and map the response element used by progesterone (P) to upr... | DisGeNET | Detail |
| To investigate the molecular mechanisms controlling cancer and hemostasis, we conducted a case-contr... | DisGeNET | Detail |
| These findings have functional implications in the pathobiology of thromboembolic events and regulat... | DisGeNET | Detail |
| The effect of tumor expressed TF and TFPIα and TFPIβ on survival was investigated in a merged breast... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- dbSNP
- rs386626619 dbSNP
- Genome
- hg19
- Position
- chr1:94,994,729-95,007,315
- Variant Type
- snv
Genome browser